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Abstract
Background: Casemix adjusted in-hospital mortality is one of the measures used to improve quality of care. The
adjustment currently used does not take into account the effects of readmission, because reliable data on
readmission is not readily available through routinely collected databases. We have studied the impact of
readmissions by linking admissions of the same patient, and as a result were able to compare hospital mortality
among frequently, as opposed to, non-frequently readmitted patients. We also formulated a method to adjust for
readmission for the calculation of hospital standardised mortality ratios (HSMRs).
Methods: We conducted a longitudinal retrospective analysis of routinely collected hospital data of six large non-
university teaching hospitals in the Netherlands with casemix adjusted standardised mortality ratios ranging from
65 to 114 and a combined value of 93 over a five-year period. Participants concerned 240662 patients admitted
418566 times in total during the years 2003 - 2007. Predicted deaths by the HSMR model 2008 over a five-year
period were compared with observed deaths.
Results: Numbers of readmissions per patient differ substantially between the six hospitals, up to a factor of 2. A
large interaction was found between numbers of admissions per patient and HSMR-predicted risks. Observed
deaths for frequently admitted patients were significantly lower than HSMR-predicted deaths, which could be
explained by uncorrected factors surrounding readmissions.
Conclusions: Patients admitted more frequently show lower risks of dying on average per admission. This decline
in risk is only partly detected by the current HSMR. Comparing frequently admitted patients to non-frequently
admitted patients commits the constant risk fallacy and potentially lowers HSMRs of hospitals treating many
frequently admitted patients and increases HSMRs of hospitals treating many non-frequently admitted patients.
This misleading effect can only be demonstrated by an analysis over a prolonged period, but occurs, in effect,
every day of the year. This finding is relevant for all countries where hospitals use HSMR for monitoring and
improving hospital performance. The use of ‘admission frequency’ as additional adjustment variable may provide a
more accurate HSMR.
Background
In various countries in the world, risk adjusted in-hospital
mortality ratios are currently calculated using routinely
collected data. The variations seen in crude mortality for
which adjustment is needed, may be attributed to various
sources, including variations in: registration data, casemix,
quality of care and chance [1]. After adjustment for case-
mix, the hospital standardised mortality ratio (HSMR) can
be used as a tool for hospitals to analyse their death rates
by comparing their riskadjusted mortality with the
national average, establishing a starting point for improve-
ment of hospital outcomes [2]. In some countries HSMRs
are also made publicly available for the benefit of for
example: the patient, the politician, the hospital manager
and the clinician. This public reporting potentially may
result in league tables, suggesting that the ranking reflects
differences in quality of care. A somewhat more subtle
approach is being applied in the UK by combining stan-
dardised mortality ratios with other safety indicators, in
order to establish hospital safety rankings. These rankings
are publicised in the “How Safe is Your Hospital” guide
[3], compiled by researchers at the Dr Foster Intelligence
Unit at Imperial College London. However, publicly
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comparing and judging hospital performances in this way
is heavily disputed [4,5] at the moment. Some publications
mention the Netherlands as one of the countries where
HSMRs are also made publicly available [6,7], yet up to
and including 2008 the HSMRs have not been publicised
with the exception of a few hospitals that voluntarily put
their values on the web. Mandatory publication was
planned to start in 2010, based on admission data from
2009, and various articles suggest that the quality of the
Dutch HSMRs is sufficiently high to justify publication.
Heijink et al [8] for example state that they did not find
evidence that the HSMR cannot be used as an indicator to
monitor and compare hospital quality in the Netherlands.
However there is some controversy around this subject
and the Dutch Ministry of Health recently decided to
postpone mandatory publication for at least one year,
because there were doubts about the reliability and validity
of the current figure [9]. This decision was based on the
outcomes of a study [10] conducted by Santeon, a group
of six large non-university teaching hospitals in the Neth-
erlands (Additional file 1: Table S1), confirming indeed
why publicly comparing HSMRs may not be a good
idea [4].
One of the findings of this Dutch study [10], not being
addressed in [4], showed large differences between the
hospitals with respect to numbers of readmissions per
patient, if measured over a prolonged period of time.
Currently the HSMR in the Netherlands is not adjusted
however for any form of readmission. In the UK the
HSMR is adjusted for readmission for acute cases, but
not for a prolonged period of time.
The association between readmissions and the HSMR
is mentioned in a paper by Jarman [11]. The effects of
adjusting for readmissions are described as follows: “ ....
There is also not much difference between normal
HSMRs based on all admissions and those based on only
one (e.g., the last) admission in a year. ....”. We interpret
this finding as follows: If a patient visits the hospital
more than once that year, then any one of the admis-
sions would represent the contribution of that patient to
the HSMR ratio. Using a limited part of the patient’s
admission history, would, on average, not make a differ-
ence to the HSMR of that hospital. This may suggest
that adjustment for readmission would not make sense.
Using this method, we question whether a period of
one-year is sufficiently long to embrace all the effects of
readmission and indeed whether all the risk conditions
surrounding readmissions can be properly addressed. A
more recent article by Jarman [2] however, does address
the need to investigate adjustment for readmissions as
follows: “ ... further improvements to the case-mix model
are being evaluated. The numbers of previous admissions
within a given time period, which requires the linking of
admissions of the same patient, could be of potential
use....”. In our publication we will share how differences
in numbers of previous admissions made an impact
upon the HSMRs of the hospitals and what can be done
to improve the HSMR model used.
In order to allow comparisons to be unbiased, adjust-
ment for the differing risks of patient specific variables,
that is the casemix, is necessary. Risk factors used in the
adjustment may be related in different ways to the in-
hospital risks. Ignoring non-constant risk relationships
commits the constant risk fallacy. Attributing the resi-
dual (unexplained) variation from case-mix adjusted
mortality to quality of care commits the “case-mix
adjustment fallacy” [1,12]. An example of this phenom-
enon applied to the HSMR model in the UK is
described by Mohammed et al [6]. Here the interaction
of two casemix adjustment variables - comorbidity and
admission type - with hospitals was considerable. These
effects could be explained by differences in clinical cod-
ing and admission practices across hospitals rather than
by differences in the quality of care. The lesson we learn
from this study is that variables being adjusted may
mean different things to different hospitals. Since adjust-
ment of variables is ‘admission-based’, one can ask
whether the practice of admitting and readmitting in
itself may be prone to the constant risk fallacy as well.
In other words, does an admission of a patient mean
the same thing to one hospital as it means to another
hospital admitting ‘the same patient’? More specifically
attuned to our study: are the risk conditions the same
for a patient being admitted only once compared to
admissions of a frequently admitted patient? In order to
analyse this, we addressed the following research ques-
tions using HSMRs from six Dutch hospitals:
1. Are there substantial differences in the numbers
of readmissions within a given time period between
the six hospitals?
2. Is there a significant association between HSMRs
and numbers of readmissions per patient?
3. Does the casemix change as readmissions increase
and how does it change?
4. How do we adjust for readmission in order to
provide more accurate HSMRs and standardised
mortality ratios (SMRs) on diagnostic level?
Methods
Setting
’Santeon’ (Additional file 1: Table S1) is a group of six
large non-university teaching hospitals geographically
spread over the Netherlands with HSMRs ranging from 65
(favourable) to 114 (poor) over the years 2003 - 2007 and
an overall HSMR value of 93 (table 1). This group of coop-
erating hospitals covers about 10% of the total Dutch hos-
pital healthcare in terms of the number of admissions.
van den Bosch et al. BMC Health Services Research 2011, 11:57
http://www.biomedcentral.com/1472-6963/11/57
Page 2 of 11
Statements
1. This study did not concern experimental research,
neither research carried out on humans, neither any
experimental research on animals.
2. The dataset used in this study concerned a selec-
tion of the ‘Landelijke Medische Registratie’
(National Medical Registration) covering data from
the six Santeon hospitals over the years 2003 - 2007.
Each of the boards of the six hospitals approved the
usage of their part of the dataset.
HSMR model used in this study
The HSMR of a hospital is based on the predicted risks
of death per admission. For a certain period of time, for
example a year, the HSMR is calculated with the formula:
HSMR = 100 times
(
number of observed deaths
)
/
(
sum of predicted risks of death of all admissions
)
The Dutch HSMR model 2008 (DHM-2008) used in
this study accounts for at least 70% of hospital mortality.
Here adjustment is made for: age, sex, admission type
(emergency or non-emergency), length of stay, year of
discharge, socio-economic deprivation, comorbidity and
CCS diagnostic group based on ICD-9 coding. The
DHM-2008, was developed by the Dr Foster Unit in the
UK in cooperation with ‘Prismant’ and the ‘PraktijkIn-
dex’ in the Netherlands. DHM-2008 is very well
described in [2] and resembles the UK model. Differ-
ences with the UK model concern: the use of day cases
(not used in UK) and the use of 50 CCS groups in NL
(based on ICD-9 coding) versus 56 CCS groups (based
on ICD-10 coding) in UK of which 42 in common.
Furthermore the UK model adjusts for palliative care,
source of admission and for the number of previous
emergency admissions; DHM-2008 does not adjust for
any of these three. Calculations of the HSMR-results
were carried out by Prismant, an independent research
and advisory agency for the Dutch health service.
Definition of Readmission
The term ‘readmission’ is often used for unplanned read-
missions within a limited period of time, for example
30 days, for treatment of the same disease. Planned
readmissions are another frequently occurring form of
readmitting patients, particularly for chronically ill
patients, for example suffering from neoplasms. In these
cases treatment schemes may span a prolonged period of
time, even a number of years. Furthermore, a patient may
visit the hospital for a different disease than during a pre-
vious admission, which in a way can be seen as a read-
mission as well. In our study we considered all these
cases as ‘readmissions’ of the same patient over the study
period of five years. We adopted the term ’nth admission’
[13], according to the definition, applying to admissions
that occurred after the 6th admission, where ‘nth’ is an
ordinal number - e.g., seventh, eighth, etc. We used the
term also for n = 1, 2, ...6.
Identifying the nth admission of a patient
Routinely collected data on hospital admissions in the
Netherlands are being collated in the national medical
registration LMR (’Landelijke Medische Registratie’). In
general, readmissions are not adequately registered in
the LMR. In order to be able to identify the value of n
of the nth admission of a patient, we used the dates of
discharge combined with the patient’s identification
number.
Admission frequency
HSMR-variable data is collected on a ‘per admission’
basis. The model considers each admission to be an
independent stochastic experiment (like repeatedly
throwing a dice), separate from previous admissions, for
which a risk of death number is predicted and accumu-
lated into the denominator of the HSMR. The admission
represents a container or proxy for risk conditions
around a single hospitalization of a patient. However,
comparing mortality ratios of hospitals for a certain
fixed period of time, one might not only be interested in
the quality of single admissions, but also in the quality
of the end result - was the patient discharged alive after
the last admission in a row? The patient is the primary
subject of interest for hospitals for whom they bear the
responsibility for care. For the purpose of this study we
introduce a new variable that may serve as a risk proxy
more attuned to the patient, taking into account all the
patient’s admissions during the study period. Since risk
conditions may be linked to how often a patient was
Table 1 Admission numbers and HSMR values years 2003 - 2007 Santeon hospitals and overall value
Hospital Overall value
A B C D E F
Number of admissions over period 2003 - 2007 114714 78417 46322 66802 61333 50978 418566
HSMR value over period 2003 - 2007 96 114 82 65 109 94 93
95% Confidence Interval (93 - 99) (110 - 118) (78 - 86) (62 - 67) (105 - 113) (90 - 99) (91 - 94)
* Hospitals are presented in random order and labelled A - F.
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admitted in total, we allocated each patient to a distinct
patient class P(m), where:
Admission frequency m = the number of times a
patient was admitted during a fixed period of time
(Occasionally we use the number of times a patient
was admitted after the initial admission, in which case
we apply the term ‘readmission frequency’ = m-1).
The second research question formulated tests the
capability of the current HSMR model for predicting
mortality accurately for these classes. Based on this we
draw conclusions on whether the new variable m turns
out to be a valuable addition to the HSMR model. This
idea was suggested but, as far as known, not further
explored by Jarman [2].
Admission view versus Patient view
The dataset of all of the 418566 admission records can
be grouped in different ways or views. We have studied
and compared mortality risks based on the following
two different views:
• Admission view: this view is based on nth admis-
sion classes A(n) where A(1), A(2), etc. represent all
admission records for all first admissions, all second
admissions, etc. For example each patient in class A
(3) contributed one admission record to class A(3),
but also one to A(1) and one to A(2).
• Patient view: this view is based on admission fre-
quency classes P(m) representing all admission records
of patients who have been admitted exactly m times
over the five-year period. For example: each patient in
class P(3) contributed exactly three admission records
to this class and did not contribute any admission
record to any other patient view class. In fact, patients
with equal admission frequencies are clustered in dis-
tinct mutually exclusive classes, in contrast with the
admission view where one patient may contribute
admission records to many classes. For example every
patient contributes one admission record to class A(1).
Calculating mortality figures
We calculated crude mortality, predicted mortality
(based on DHM-2008) and standardised mortality ratios
(SMRs) by applying the HSMR formula for each class A
(n) and P(m) for m,n = 1, 2, 3, ... In order to preserve
power we have grouped the results of the higher (m >
4) classes P(m) as follows: m = 5, 6 into one group, m =
7 - 9 into one group, m = 10 - 20 into one group, and
m > 20 into one group. Similarly for A(n). For the
SMRs we also calculated the 95% confidence intervals.
We analysed the association between observed and pre-
dicted outcomes, and goodness of fit for both views.
Results
During the five-year study period 240662 patients
accounted for 418566 admissions in total. 164884
patients (69% of total patients) concerned ‘first-and-
only’ admissions. The other 75778 patients (31% of total
patients) who were admitted more than once accounted
for 253682 admissions (61% of total admissions) of
which 177904 were readmissions (43% of total
admissions).
Variations in admission frequencies
We analysed the distribution of the admission frequency
per patient class P(m) per hospital (table 2). For m = 1
hospital B has the highest percentage admissions (46%
of total), hospital D the lowest (29% of total). For P(m >
7) hospital D has high scores, for example: 9% of the
admissions concerned patients being admitted more
than 20 times (P(m > 20)), whereas for hospitals E and
F this percentage amounts to 0,6%. We also analysed
the inter-hospital variation of the average admission fre-
quency on the level of the 12 main CCS diagnostic
groups (figure 1). The first three diagnostic groups
shown - neoplasms, heart diseases and respiratory dis-
eases - cover two thirds of all readmissions. For these
diagnostic groups we calculated the ratio between the
highest and the lowest observed hospital average of
readmission frequencies. For neoplasms, hospital D (3.3
readmissions) and hospital B (1.1 readmissions) differed
by a factor of 3. For heart diseases and respiratory dis-
eases the ratio between highest and lowest amounted to
1.8 and 1.7 respectively. Overall (bottom line of figure
1) hospital D has the highest average readmission fre-
quency (1.14) and hospital B and F have the lowest aver-
age (0.57); a factor of 2 difference between the highest
and the lowest.
Table 2 Distribution of number of (re)admissions over
Patient view classes m for each of the six hospitals
Percentages of admissions of total admissions per
hospital
Patient view
class
A B C D E F All
hospitals
P(m = 1) 39.1% 46.0% 37.7% 29.3% 38.9% 45.3% 39.4%
P(m = 2) 19.0% 20.8% 20.5% 17.3% 22.4% 21.2% 20.0%
P(m = 3) 10.2% 10.3% 12.3% 10.6% 12.6% 11.2% 11.0%
P(m = 4) 6.2% 6.3% 8.2% 6.6% 7.4% 6.8% 6.8%
P(m = 5, 6) 7.4% 6.5% 9.4% 8.1% 8.8% 7.3% 7.8%
P(m = 7-9) 5.8% 4.6% 5.8% 6.7% 5.2% 4.4% 5.5%
P(m = 10-20) 7.7% 3.9% 4.7% 12.2% 4.2% 3.2% 6.3%
P(m > 20) 4.6% 1.6% 1.5% 9.1% 0.6% 0.6% 3.3%
Total 100% 100% 100% 100% 100% 100% 100%
* Hospitals are presented in random order and labelled A - F.
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Mortality per patient view class and per admission view
class
In table 3 the total results of mortality calculations are
shown from the perspective of the patient view classes.
The row of class P(m = 1) shows the outcomes for all
164884 patients who were admitted exactly once, row
P(m = 2) for 41876 patients admitted exactly twice,
and so on. The crude mortality per patient for first-
and-only admissions amounts to 5.4%. For m = 2
through to m = 9 we see an average growth in mortal-
ity of roughly 1% per patient view class increment. For
m = 10 through to 21+ the crude mortality per patient
class does not show growth anymore and stabilizes
around 13%. Table 3 also shows that DHM-2008
0,0 0,5 1,0 1,5 2,0 2,5 3,0 3,5
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Figure 1 Distribution number of readmissions divided by number of patients per hospital per main CCS diagnostic group *. The chart
is showing the average number of readmissions. The six hospitals are labelled A - F. Each diagnostic group title also shows readmission sample
sizes, for example there were 55642 readmissions for neoplasms in total.
Table 3 Mortality figures per Patient view class m: crude mortality per patient and per admission, predicted mortality
per admission
Observed number of Crude mortality per DHM-2008 predicted
Patient view class patients admissions deaths patient admission number of deaths mortality per admission
P(m = 1) 164884 164884 8836 5.4% 5.4% 6971 4.2%
P(m = 2) 41876 83752 2868 6.8% 3.4% 3363 4.0%
P(m = 3) 15356 46068 1377 9.0% 3.0% 1899 4.1%
P(m = 4) 7064 28256 727 10.3% 2.6% 1153 4.1%
P(m = 5, 6) 6055 32490 695 11.5% 2.1% 1302 4.0%
P(m = 7-9) 2938 22795 404 13.8% 1.8% 820 3.6%
P(m = 10-20) 2063 26364 265 12.8% 1.0% 714 2.7%
P(m > 20) 426 13957 55 12.9% 0.4% 157 1.1%
Total 240662 418566 15227 6.3% 3.64% 16379 3.9%
* The numbers represent totals of the six hospitals. The crude mortality per patient stabilises around 13% after 10 (re)admissions. The predicted mortality per
admission increasingly differs (higher) from observed mortality for increasing patient view classes. The statistical significance of this is shown in table 5 by means
of corresponding standardised mortality ratios and 95% confidence intervals.
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predicts a decline in mortality per admission from 4.2%
(P(m = 1)) to 1.1% (P(m > 20)).
In table 4 the results of mortality calculations are
shown from the perspective of the admission view
classes. Row A(n = 1) shows the outcomes for all of
the 240662 patients being admitted for the first time.
From these patients, 75778 were admitted at least a
second time, shown in row A(n = 2), etc. In this case,
going from A(n = 1) to A(n > 20), a decline of mortal-
ity per admission from 4.1% to 1.1% is predicted by
DHM-2008.
In the patient view the number of observed deaths for
first-and-only admissions (P(m = 1)) is clearly higher
than predicted and for P(m = 2) - P(m > 20) lower
(table 3). In the admission view the differences are smal-
ler (table 4).
From tables 4 and 5 we can calculate the standardised
mortality ratios for both views via the ratio of observed
deaths and predicted deaths per category. Table 5 shows
the results, including 95% confidence intervals (p <
0.0001). Figure 2 presents a graphical representation of
this. In the patient view the SMRs decline from 127 (P
(m = 1)) to 35 (P(m > 20)) and none of the correspond-
ing 95% confidence intervals includes the expected over-
all HSMR value 93.0 (95% CI: 91.5 - 94.5). This shows a
significant association between patient view categories
and SMRs indicating a lack of model fit. In the admis-
sion view however, the SMRs fluctuate between 90 and
99 and all corresponding 95% confidence intervals
include the overall HSMR value 93.0 (95% CI: 91.5 -
94.5) indicating a good fit of the HSMR model for this
view, which we will discuss later.
Casemix risk profile for the nth admission
Finally, we also studied the variation over the nth admis-
sion classes of five casemix variables (table 6). Year, sex
and social deprivation are considered less relevant
variables for this. We split the table into patient and
admission specific property groups. Variations in case-
mix for nth admissions for n going from 1 to 21+ can be
characterized by: an average age that initially increases
from 61 (n = 1) to 66 years (n = 4) and then gradually
drops to 59 years; a steady increase of comorbidity as
indicated by a diminishing contribution of the two low-
est and an increasing contribution of the higher Charl-
son indices; a predominance of heart diseases for lower
values of n and a predominance of neoplasms for higher
values of n; a decrease of emergency admissions; a
decrease of lengths of stay (for n > 3). As readmissions
increase the casemix changes as indicated by the combi-
nation of variations of these five casemix variables.
These changes are associated with a decline in mortality
for n > 4 as predicted by DHM-2008 (table 4).
Discussion
(Re)admission frequencies show substantial variations
between the hospitals. For example: the overall value of
the readmission frequency of hospital D equals double
the value of hospital B and F. For the main CCS diag-
nostic group neoplasms, this value for hospital D equals
even three times the value of B. We conclude that there
are substantial differences in the numbers of readmis-
sions within a given time period between the six
hospitals.
Patients with higher admission frequencies bear lower
predicted risks per admission, which can be explained
by shifts in the casemix. For the patient view however,
lowering of risks is only partly predicted by DHM-2008,
since the amount of predicted deaths compared to
observed deaths turned out to be relatively low for first-
and-only admissions and high for readmissions. The
corresponding standardised mortality ratio in the patient
view is high for class P(m = 1) (127) and low for the
other classes (gradually dropping to 35 for P(m > 20))
Table 4 Mortality figures per Admission view class: crude mortality per admission and predicted mortality per
admission
Admission view class Observed number of Crude mortality DHM-2008 predicted
admissions deaths per admission number of deaths mortality per admission
A(n = 1) 240662 8836 3.7% 9783 4.1%
A(n = 2) 75778 2868 3.8% 2981 3.9%
A(n = 3) 33902 1377 4.1% 1389 4.1%
A(n = 4) 18546 727 3.9% 740 4.0%
A(n = 5,6) 19124 695 3.6% 714 3.7%
A(n = 7-9) 12634 404 3.2% 421 3.3%
A(n = 10-20) 12483 265 2.1% 293 2.2%
A(n > 20) 5437 55 1.0% 57 1.1%
Total 418566 15227 3.6% 16379 3.9%
* The numbers represent totals of the six hospitals. Predicted mortality per admission is in line with observed mortality for all admission view classes. The
statistical significance of this is shown in table 5 by means of corresponding standardised mortality ratios and 95% confidence intervals.
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compared to the overall average of 93. In contrast to
this we found that the standardised mortality ratios per
nth admission view class are approximately as predicted,
fluctuating around 93. DHM-2008 demonstrates quite a
fair goodness of fit for the nth admission view classes.
This result matches the findings of Jarman [11], where
no differences in HSMR were detected by picking nth
admissions for any value of n. At the same time
however, a comparison of predicted and observed deaths
for the patient view classes does not demonstrate a good
fit for the model. The question now arises why DHM-
2008 should be suited to fit the nth admission view and
not be suited to fit the patient view? As we will explain
below, different admission frequency classes of the
patient view may incur risk differences, not detected by
the known adjustment variables. In that case, comparing
Table 5 Standardised mortality ratios (SMRs) for patient view and for admission view
Patient
View
SMR per Patient View
Category
Lower 95%
CI
of SMR
Upper 95%
CI
of SMR
Admission
View
SMR per Admission View
Category
Lower 95%
CI
of SMR
Upper 95%
CI
of SMR
P(m = 1) 126.8 124.1 129.4 A(n = 1) 90.4 88.5 92.3
P(m = 2) 85.3 82.2 88.5 A(n = 2) 96.0 92.5 99.6
P(m = 3) 72.5 68.7 76.5 A(n = 3) 99.2 94.1 104.6
P(m = 4) 63.1 58.6 67.8 A(n = 4) 98.1 91.1 105.5
P(m = 5, 6) 53.4 49.5 57.5 A(n = 5, 6) 97.4 90.3 104.9
P(m = 7-9) 49.3 44.6 54.3 A(n = 7-9) 95.8 86.7 105.6
P(m = 10-
20)
37.1 32.8 41.8 A(n = 10-20) 90.4 79.9 102.0
P(m > 20) 34.9 26.3 45.5 A(n > 20) 96.1 72.4 125.1
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these classes would commit the constant risk fallacy and
establishing a model fit along the lines of the patient
view would be preferred to a fit along the lines of the
admission view.
We will demonstrate this point by three examples that
show mechanisms, lowering risks for higher admission
frequencies and having nothing to do with higher qual-
ity of care:
Example 1: Admission policies may increase the
number of readmissions without proportionally
increasing real risks. One hospital may systematically
combine the diagnosis and treatment into a single
admission. Another hospital may have an admission
for diagnosis and a second one for treatment, being
granted a double predicted risk count, most likely
without doubling of real risk, but doubling the
expected risk.
Example 2: Hospitals may show different treatment
practices in the frequency with which chronically ill
patients are admitted for the same disease. For
example readmission frequencies for the treatment
of neoplasms in hospitals B and D differ on average
by a factor of 3. This difference can be explained by
differences in balance between inpatient versus out-
patient treatments (late versus early adopters of a
trend moving from inpatient toward outpatient
treatment, for example [14]). The predicted risk con-
tribution for hospital D may thus be tripled
compared to B, but it is not likely that patients of D
are being exposed to a tripled real risk. On the con-
trary, the mortality risk per patient stabilizes around
13% if admitted 10 or more times (table 3). Every
incremental admission for chemotherapy further
increases the denominator of the HSMR, but on
average does not increase the observed mortality, the
numerator, further.
Example 3: Patient referrals to tertiary care, fre-
quently occurring in the Netherlands, may cause dif-
ferences. The transfer of a patient back and forth
most often is an advantage for the referring hospital,
as they count a double admission, while the hospital
to which the patient is being referred is at a disad-
vantage because they only count for one admission.
On top of this the latter hospital has to deal with
the risk of conducting a potentially complicated
medical procedure. It is unlikely that a patient under
these circumstances will experience a doubling of
risk in the referring hospital.
Another plausible mechanism may be hidden in the
physical condition of frequently readmitted patients. If
these patients are unexpectedly resilient, they will domi-
nate higher admission frequency groups through natural
selection and consequently cause lower undetected risks,
compared to lower admission frequency groups. If this
hypothesis is valid, it might become visible as well in
patient specific casemix properties that are known to us
Table 6 Values/distributions of major casemix variables for which adjustment is done by DHM-2008 per nth Admission
for six hospitals
A A A A A A A A
(n = 1) (n = 2) (n = 3) (n = 4) (n = 5,6) (n = 7-9) (n = 10-20) (n > 20)
Number of admissions 240662 75778 33902 18546 19124 12634 12483 5437
Patient specific casemix properties
Average age at nth discharge (years) 61.2 64.7 65.5 65.5 64.8 63.7 62.4 59.0
Distribution of Charlson indices:
0 68% 65% 60% 55% 49% 42% 37% 31%
1 20% 17% 16% 15% 13% 10% 6% 4%
2 and 3 10% 17% 22% 27% 35% 45% 54% 60%
4, 5 and 6 2% 2% 2% 3% 3% 3% 4% 5%
Distribution of Admissions per main diagnostic CCS group:
Neoplasms 13% 20% 25% 31% 40% 52% 65% 72%
Metabolic & shock etc 4% 5% 6% 7% 8% 9% 12% 14%
Heart disease 40% 34% 29% 25% 20% 13% 7% 2%
Respiratory disease 11% 11% 12% 12% 11% 9% 6% 3%
Gastro-intestinal disease 13% 10% 9% 8% 6% 4% 3% 2%
Other 7 main CCS groups 21% 19% 19% 17% 15% 12% 8% 6%
Admission specific casemix properties
Distribution of emergency admissions 43% 37% 39% 37% 34% 28% 18% 7%
Average length of stay (days) 6.8 7.2 7.0 6.5 6.0 5.0 3.4 1.8
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such as age and comorbidity (table 6). The average age
of frequently admitted patients indeed is decreasing for
the highest values of n, indicating a fitter population.
The comorbidity is increasing however; a logical conse-
quence of the fact that we applied the notion of read-
mission for any disease. So patients with more co-
morbidity may be admitted more often for the various
diseases they suffer from. It also indicates higher vulner-
ability and in that case would contradict the hypothesis.
Although the hypothesis looks appealing, we cannot
proof its correctness with the data currently available.
Looking back at the admission history of a frequently
admitted patient, the additional risk-lowering factors
just described, may have come into play already after
the patient’s first admission. The nth admission view
constitutes a cross-section of various patient view
groups, each having their own additional risks. Conse-
quently the nth admission view cannot discriminate
additional risk differences and is not suited to be used
for readmission adjustment. Instead, we think the vari-
able ‘admission frequency’ of the patient view should be
used for this purpose. Patient views are showing why
DHM-2008 predicts too high a risk for a frequently
readmitted patient, as illustrated by the following case
that we observed:
Patient × of hospital D contributed 3.1 predicted
deaths to the denominator of the HSMR through seven
successive admissions within six months. A single patient
however can maximally contribute a value of 1 - in case
of death - to the numerator of the HSMR.
Numerous examples alike became available in our
study, for example: we found 174 patients in hospital D,
each of whom contributed more than 1 predicted death
to the denominator of the HSMR due to various read-
missions. In total these contributions in hospital D
added up to 232 predicted deaths, whereas ‘only’ 75
deaths were observed in this group. Clearly the number
of deaths predicted by DHM-2008 for frequently
admitted patients is being overestimated.
A final illustration of this phenomenon is shown in
figure 3: a scatter diagram where we plotted the HSMRs
as well as the SMRs of the three main CCS diagnostic
groups that show the largest variations in readmission
frequency - neoplasms, heart diseases and respiratory dis-
eases - against the readmission frequency (see also figure
1). In all cases there is a downward trend: higher read-
mission frequencies corresponding with lower (H)SMRs.
We conclude that there is a significant association
between HSMRs and numbers of readmissions per
patient.
Since the study involved five consecutive years, we
were not able to capture the complete patient view.
Patient view sequences that started before 2003 and
continued to emerge in the period 2003 - 2007 were
truncated. The same happened with sequences that
started during the period 2003 - 2007 and continued in
the years thereafter. Consequently the picture will never
be complete. For each patient being admitted at least
twice, we calculated the time elapsed between the date
of the first and the date of the last discharge. For 63%
of these patients, the time elapsed amounted to less
than one year and for 91% less than 3 years, suggesting
that the larger part of the effect has been captured.
How can HSMRs be adjusted for the effects of read-
missions? For that purpose, an additional adjustment
variable ‘admission frequency,’ as used in this study in
the patient view, may be applied. After adjustment, the
SMRs of the patient view classes in our study will fluc-
tuate around 93. As a consequence the goodness of fit
for the admission view will be lost. However, this does
not provide us with a principal problem since the divi-
sion into admission frequency classes (patient view) is
along the lines of identified and distinct risk classes for
which adjustment is clearly needed. Nth admission
classes turn out to be meaningless in terms of risk
differentiation.
In particular for the higher admission frequencies, a
prolonged measurement period of various years was
needed in order to make visible the effects we described.
For example the average time which elapsed between
the first and last date of discharge for patient view class
P(m > 20), amounted to 2.5 years. This does not mean
however that having many patients in class P(m > 20),
does not have an effect if measured for only one year.
Ideally the adjustment for readmission would be based
on an ‘admission counter’ in the file of each patient that
is being increased by 1 after every new readmission.
Since such counts are not being kept, an approach
along the lines of this study, awkward as it might be,
will be necessary.
A final remark concerns the following: (frequent)
readmissions are sometimes taken to be a proxy indica-
tor for poor quality of care. But instead of working
against the hospitals with higher readmission frequen-
cies the current HSMR seems in that case to work in
favour of those hospitals, underlining the following
statement: If HSMRs in the Netherlands ever will be
publically reported and used to compare hospitals, then
the issues raised in [4] need to be resolved and, on top
of this, adjustment for readmission will be necessary. If
HSMRs and particularly SMRs on diagnostic level are
used by hospitals as a starting point for quality improve-
ment [2] - a better idea for usage of the HSMR indicator
- then adjustment for readmission will be necessary as
well, in order to prevent misleading signals to be gener-
ated. Hospitals will in that case better be able to avoid
falsely acting upon too high SMR values as well as to
avoid falsely non-acting upon too low SMR values.
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Conclusions
This study has shown that patients admitted more fre-
quently experience a lower risk of dying per admission.
The HSMR model used, detects lower risks for higher
admission frequency groups. However the observed
mortality of these groups demonstrate the real risks to
be even lower, indicating differing risk conditions
between the groups. Consequently, comparing admis-
sions of patients from different admission frequency
groups, as done by the current HSMR model, commits
the constant risk fallacy. The study showed substantial
variations in the overall distribution of readmission fre-
quencies, up to a factor of 2, between the six hospitals.
As a result hospitals with high admission frequencies
experience unadjusted decrease of risks and hospitals
with low admission frequencies experience unadjusted
increase of risks. These misleading outcomes can only
be demonstrated by analysis over at least three years,
but is in effect every day. As 43% of all admissions in
this study concerned readmissions, the impact on the
HSMR of some hospitals may be substantial. This find-
ing is relevant for all countries where hospitals use (H)
SMRs for monitoring and improving hospital perfor-
mance. Further research to identify how the effects of
readmissions may impact the HSMR in other countries
is clearly warranted. The accuracy of the HSMR may
improve by taking admission frequency as an additional
adjustment parameter.
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